Thus, although the transition between adenoma and carcinoma is regarded as the key first step in CRC progression, our data supports a refined model that emphasizes a role for differences between low- and high-grade adenomas, with the latter sharing key genetic traits with carcinomas, such as TP53 mutation accompanied with altered expression. This evidence concerns the gene TP53 and carcinoma.